| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |